Submissions from 2024
A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR), Manmeet Ahluwalia, Ahmad Ozair, Mainak Bardhan, Dilanis Perche, Muni Rubens, Yazmin Odia, Rupesh Kotecha, Daniel Leon Ariza, Michael McDermott, Ana Cristina Sandoval Leon, Reshma Mahtani, Shreyas Bellur, and David Peereboom
Assessing Prescribing Trends and Pharmacist Role in Optimization of IV Iron Sucrose, Katherine Fernandez, Heidi Clarke, Erika Dittmar, Jonathan Kline, and Stephanie Palma
Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease, Haley Appel, Muni Rubens, Mukesh Roy, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Zhijian Chen, Manmeet Ahluwalia, and Yazmin Odia
Optimization of long-acting erythropoietin stimulating agents in dialysis patients during transitions of care to a community hospital, Ryan Falcon, Erika Dittmar, Radhan Gopalani, Stephanie Palma, Heidi Clarke, Jessica Wine, and Leyner Martinez
Racial Disparities in Blood Pressure at Time of Acute Ischemic Stroke Presentation: A Population Study, Felipe De Los Rios La Rosa
Racial Disparities in Blood Pressure at Time of Acute Ischemic Stroke Presentation: A Population Study, Felipe De Los Rios La Rosa
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon, Yazmin Odia
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma, Yazmin Odia, Doured Daghistani, and Matthew Hall
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall
ARISE I Consensus Statement on the Management of Chronic Subdural Hematoma, Guilherme Dabus
Most Promising Approaches to Improve Brain AVM Management: ARISE I Consensus Recommendations, Guilherme Dabus
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
Pre-Hospital Telecommunication Pilot Study: A Feasibility and Technical Review, Ashley Bolling, Orlando Vallone, Starlie Belnap, Nina Cruz, and Felipe De Los Rios La Rosa
Health Factors Associated With Development and Severity of Poststroke Dysphagia: An Epidemiological Investigation, Felipe De Los Rios La Rosa
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review, Michael McDermott
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review, Michael McDermott
Measurement of Functional Brain Network Connectivity in People with Orthostatic Tremor, Diego Torres Russotto
Open-window craniectomy for the removal of frontal sinus mucosa to prevent a delayed mucocele: illustrative case, Michael McDermott
Neuromodulation Techniques in Chronic Refractory Coccydynia: A Narrative Review, Richard Morgan
The importance of considering competing risks in recurrence analysis of intracranial meningioma, Michael McDermott
Epigenetic reprogramming shapes the cellular landscape of schwannoma, Michael McDermott
Focused update to guidelines for endovascular therapy for emergent large vessel occlusion: large core and basilar artery occlusion patients, Guilherme Dabus
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial, Robert Rothrock, Maria Avendano, Susana Herrera, Haley Appel, Suyen Ramos, Amy Starosciak, Muni Rubens, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial, Robert Rothrock, Ahmad Ozair, Maria Avendano, Michael McDermott, Susana Herrera, Haley Appel, Amy K. Starosciak, Daniel Leon, Muni Rubens, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha